| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $300.00K | $0.00 | $0.00 | – | – |
| Cost of Revenue | $200.00K | $0.00 | $0.00 | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | $509.70M | $446.90M | $347.40M | $358.30M |
| R&D | $493.90M | $357.70M | $276.40M | $171.50M | $64.30M |
| SG&A | – | – | $168.40M | $165.10M | $176.70M |
| Operating Income | -$729.30M | -$509.70M | -$446.90M | -$347.40M | -$358.30M |
| Interest Expense | – | – | – | – | $1.00M |
| Tax Expense | $300.00K | $200.00K | $500.00K | $0.00 | $0.00 |
| Net Income | -$618.20M | -$536.80M | -$457.90M | -$317.30M | -$347.80M |
| EPS (basic) | -0.9900 | -1.4200 | -1.6900 | -1.3200 | -3.1400 |
| EPS (diluted) | -0.9900 | -1.4200 | -1.6900 | -1.3200 | -3.1400 |
| Shares (diluted) | $624.31M | $376.73M | $270.41M | $240.48M | $110.84M |